Victory by another way!
—

"Some souls teach us that even in the face of darkness, light can still be shared. They give all they have, not for recognition, but to make the road easier for those who come after. To such a soul, who turned pain into purpose and science into compassion: thank you." ― Adel Hafez 

There are people who choose a profession. And then there are people whom a profession chooses, in the deepest sense of that word, because what they do and who they are cannot really be separated.

Professor Richard Scolyer was the second kind.

He was born in Australia in 1966, and from his earliest years he was drawn to science the way some children are drawn to the sea, with a curiosity that felt less like a hobby and more like a hunger. He came to believe, early and with complete conviction, that science is one of the greatest tools a human being can place in the service of another. Everything that followed in his life was, in one way or another, the living out of that belief.

He studied medicine at the University of Tasmania and the University of Sydney, and it was during those years that his true calling quietly announced itself: pathology, diagnosis, the painstaking and vital work of understanding what is happening inside a human body before it is too late. He was exceptional at it. Over the decades that followed, he became one of the world's leading scientists in the diagnosis of melanoma, a form of skin cancer, contributing to the development of methods that gave accurate answers to patients who had been living with terrifying uncertainty. The Melanoma Institute in Australia records that he received more than two thousand cases annually from across the country and abroad. He co-led the Applied Melanoma Research Laboratory. He co-authored more than eight hundred publications and books. He presented at more than four hundred conferences around the world.

Behind every one of those numbers was a face. A person sitting across a desk, waiting.

Then, in the middle of 2023, Richard found himself on the other side of that desk.

The diagnosis was not melanoma, the disease he had given his professional life to fighting. It was glioblastoma, one of the most aggressive forms of brain cancer known to medicine, a disease that grows quickly and resists almost everything thrown at it. For a man who had spent decades delivering difficult news to others with steady hands and a calm voice, the moment must have carried a particular and very private weight.

But Richard did not settle into the patient's chair in the way that might have been expected of him. He did not simply receive whatever treatment was offered and wait. Instead, he chose to go further than anyone had gone before with this type of cancer. He agreed to undergo experimental immunotherapy before surgery, a sequence that had never been tried for glioblastoma. It was not a comfortable decision, but it was a very Richard Scolyer kind of decision.

In his hospital room during those early weeks of treatment, he later said that he found himself thinking of all the patients he had sat with over the years. All the faces in which he had first seen fear, and then, after the right diagnosis and the right words, seen something shift toward hope. Now he was the one sitting in that chair, feeling what they had felt. And rather than being broken by that, he said he felt, even then, that he was still doing his work. Still fulfilling something.

Months passed. Then the results came back, and they were remarkable. Initial scans showed no visible trace of cancer. For a moment, it seemed as though a door had opened onto something extraordinary, not just for Richard, but for every patient who might walk through that door after him. He was happy, he said, not only for himself but for science, and for the people who might one day benefit from what his experience had made possible.

But the joy did not hold.

In March 2025, the tumour returned, more aggressively than before. Surgery was attempted in the first days of that month, but it could not remove the tumour completely. Richard sat with his family, looking at their faces, knowing that time was now very limited.

In a television interview with Australia's Channel Nine, he was asked directly about how much time he had left. He answered quietly: "It could be few weeks, could be few months, could be longer. I do not know." He said he was not ready to die, not out of fear, but because he still had work he wanted to finish, people he wanted to help, things he wanted to leave behind. And then, with a smile that those who saw it said was entirely genuine, he added: "I got extra time that I did not expect, and I enjoyed every moment of it."

There was no performance in that smile. No bravado. Just a man who had looked at his life honestly and found that, on balance, it had been worth living.

Richard Scolyer may not have defeated glioblastoma. Medicine, for all its extraordinary advances, has not yet found a way to do that reliably. But victory, as his life quietly insists, is not always measured in survival. He won when he turned his own diagnosis into a contribution. He won when he sat in the patient's chair and chose, still, to be a scientist. He won in every moment he refused to let fear have the last word.

He made his battle a light for those who would come after him.

And the road, for those who follow, is a little easier now because he walked it first.not remove the tumour completely. Richard sat with his family, looking at their faces, knowing that time was now very limited.

In a television interview with Australia's Channel Nine, he was asked directly about how much time he had left. He answered quietly: "It could be few weeks, could be few months, could be longer. I do not know." He said he was not ready to die, not out of fear, but because he still had work he wanted to finish, people he wanted to help, things he wanted to leave behind. And then, with a smile that those who saw it said was entirely genuine, he added: "I got extra time that I did not expect, and I enjoyed every moment of it."

There was no performance in that smile. No bravado. Just a man who had looked at his life honestly and found that, on balance, it had been worth living.

Richard Scolyer may not have defeated glioblastoma. Medicine, for all its extraordinary advances, has not yet found a way to do that reliably. But victory, as his life quietly insists, is not always measured in survival. He won when he turned his own diagnosis into a contribution. He won when he sat in the patient's chair and chose, still, to be a scientist. He won in every moment he refused to let fear have the last word.

He made his battle a light for those who would come after him.

And the road, for those who follow, is a little easier now because he walked it first.